Fearing abuse, FDA blocks generic OxyContin

... it based its decision on medical studies of OxyContin, reports of abuse and misuse, public comments and petitions. Stamford, Conn.-based Purdue said in a statement that the new labeling will provide 'important information to health care ...



via Stamford Newswire http://www.freep.com/article/20130417/BUSINESS07/304170081/1002/business